Category Archives: Biotech

Leading Industrial Contractor and Fabricator Wins ABC National Safety Excellence Award

M. Davis and Sons, Inc. has been awarded the National Safety Excellence Award, which is the industry’s leading safety laurel that honors both merit shop general and specialty contractors.

Long Beach, CA, 2018-Mar-30 — /EPR Network/ — Associated Builders and Contractors Delaware Chapter announced the winners of the prestigious Excellence in Construction award during its 28th annual celebration held in Long Beach, California.

The award was received by the construction and fabrication company M. Davis and Sons received amidst resounding applause.

MORE…

FINALLY, A REAL INNOVATION IN DENTAL CARE – THE ONLY DUAL MODE LIGHT THERAPY ELECTRIC TOOTHBRUSH LAUNCHES ON KICKSTARTER

Los Angeles, California, 2018-Mar-26 — /EPR Network/ — Bristl combines proven science of light therapy with sonic vibration to improve oral care. The company also offers a subscription service to replace brush heads, so having the best oral health is also convenient.

Available on Kickstarter on Monday, March 26th at 9am (PST)

The combination of Bristl’s features, convenience, and style make for true market disruption:

Gum Health
Visible Red light (620–750 nm in wavelength) has been clinically proven to heal gum tissue and prevent inflammation. The same technology is often used in skincare; Bristl is bringing it to the everyday tooth brushing routine.

Kill Bacteria
Visible blue light (450–495 nm in wavelength) has been clinically proven to kill and prevent oral bacteria that causes gingivitis and other gum disease. This safe and natural blue light is proven to be effective, and Bristl is proud to bring it to market.

Get Rid of Plaque
Bristl has three sonic vibration modes: regular, gentle, and off. Sonic vibration is recommended by dentists as it has the highest cleaning ability without damaging gums. The brush head is also particularly designed to reach in crack and crevices while letting light pass through the bristles.

more…

PEGGY DEL FABBRO, CEO OF M. DAVIS & SONS, APPOINTED TO WOMEN’S ENTERPRISE FORUM LEADERSHIP TEAM

The Women’s Enterprise Forum Serves as a Strategic Advisor to the Women’s Business Enterprise National Council

Wilmington, DE, 2018-Mar-15 — /EPR Network/ — Peggy Del Fabbro, CEO of M. Davis and Sons, Inc. has been appointed to 2nd Vice Chair of the Women’s Enterprise Forum, which serves on an advisory capacity for the Women’s Business Enterprise National Council (WBENC), the nation’s largest certifier of women-owned businesses and leader in women’s business development.

The Women’s Enterprise Forum provides opportunities for WBENC-Certified Women’s Business Enterprises (WBEs) to represent the voice of all women’s business enterprises and engage in networking and development activities with other WBEs, member corporations and government entities.

more…

S-ACQUISITION CORP COMMENCES TENDER OFFER OF ASTRA LOGICS, INC.

New York, 2017-May-02 — /EPR Network/ — S-Acquisition Corporation is today commencing its tender offer for all 10,000,000 shares of Second Round financing of Common Stock of Astra Logics Inc., Hong Kong, at a price of US$7.00 per share, payable in cash. The offer, which has been unanimously approved and recommended by Astra Logic’s Board of Directors is being made pursuant to the agreement between the two companies.

MORE…

GenQual and R-Pharm collaborate to deliver predictive diagnostics for novel anti-IL-6 antibody for autoimmune diseases

Seattle, WA, San Francisco, CA and Moscow, Russia, 2016-May-25 — /EPR Network/ — R-Pharm and GenQual are pleased to announce a new collaboration focused on the development of novel predictive diagnostic tools in the area of Rheumatoid Arthritis and Autoimmune diseases.

The GenQual proprietary real-time PCR platform, when applied to the genes that are involved in the manifestation of several autoimmune diseases, allows us to detect and assess single nucleotide polymorphisms. Here, allelic determination is used as potential predictor of the treatment response by the novel anti-IL6 antibody, which is currently in development by R-Pharm.

more…

BOC Sciences Released Analytical Support Services

Long Island City, New York, January 15, 2016 — /EPR NETWORK/ — Thursday of this week (January 14, 2016), BOC Sciences officially launched its analytical support service, aiming to provide all-round custom services on the base of its present services in pharmaceutical field.

BOC SCIENCES LOGO

The analytical service of BOC Sciences covers a wide range in almost every aspect of drug discovery from impurities identification, purity level testing, to right equipment suggestion for compound preparation with the aim of providing the best solutions for research conduction and maximizing the outcome with less waste in both time and cost.

more…

Regenexx Announces the Publication of “Orthopedics 2.0 – How Regenerative Medicine and Interventional Orthopedics will Change Everything” on Amazon Kindle

Released on: February 02, 2015, 4:33 am (EST)
Author: Dr. Chris Centeno
Industry: Biotech, Healthcare

Broomfield, CO, February 02, 2015 — /EPR NETWORK/ — With more than 40,000 downloads, “Orthopedics 2.0 – How Regenerative Medicine and Interventional Orthopedics will Change Everything” is now available on Amazon Kindle. The third edition of the top-selling e-book is being offered as a free download through Jan. 6, 2015.

Written by Dr. Chris Centeno, this e-book delves into the human musculoskeletal system and explains how everything works together in concert to maintain our physical wellbeing. When a single component in this chain is damaged, it can lead to a cascade of joint, spine and connective tissue problems, resulting in chronic pain.

more…

ViroCarb’s anti HIV Crowd Funding Campaign

Released on: December 01, 2014, 2:30 pm (EST)
Author: ViroCarb Inc.
Industry: Biotech, Healthcare, Pharmaceuticals

Toronto, Canada, December 01, 2014 — /EPR NETWORK/ — ViroCarb Inc. has launched a worldwide crowd funding campaign to promote the development of its new HIV infection inhibitor.

WORLD AIDS DAY – Make a donation to save lives from AIDS! Support new treatment development at: https://www.indiegogo.com/projects/funding-a-new-therapy-against-drug-resistant-hiv/x/9240077

Despite the great progress made in HIV/AIDS treatment, there is still an urgent need for new drugs, particularly for people who have had to abandon existing treatments due to HIV drug resistance and side effects.

more…

HD Biosciences, Co., Ltd. and E. J. Corey Institute of Biomedical Research Reached Agreement for Drug R&D Collaboration  

Released on: May 28, 2014, 5:11 pm (EDT)
Author: HD Biosciences Co.,Ltd. 
Industry: PharmaceuticalsBiotech

Shanghai, May 28, 2014 — /EPR NETWORK/ — HD Biosciences Co., Ltd. (HDB) and E. J. Corey Institute of Biomedical Research (CIBR) announced that they have reached a risk-sharing agreement on collaborative drug discovery and development in the therapeutic areas of infectious diseases, metabolic diseases, and oncology. This joint effort will focus on both international and Chinese markets to provide innovative medicines for unmet healthcare needs. The agreement includes lead candidate selection pre-clinical development, IND filing, clinical trials, and NDA approvals. Both companies will share financial returns from any successes or products launches.

more…

Axcellerate Pharma, New Jersey aims to become a market leader in high-value, niche offerings to the US life sciences industry

Released on: November 20, 2013, 1:10 pm
Author: TCG Lifesciences Limited
Industry: Biotech

November 20, 2013, 1:10 pm — /EPR NETWORK/ — Axcellerate Pharma establishes CMO/CRO and API manufacturing facility in New Jersey, US. Focus will be small molecule and biologics PR&D, innovative technology platforms, filling vial and bag operations, peptide synthesis, oligonucleotide production and related areas.

more…